Intraductal carcinoma of the prostate morphologic features, differential diagnoses, significance, and reporting practices

Archives of Pathology and Laboratory Medicine

Volumn 139, Issue 10, 2015, Pages 1234-1241

  Magers, Martin ^a   Kunju, Lakshmi Priya ^a   Wu, Angela ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADENOCARCINOMA; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; METABOLISM; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

ADENOCARCINOMA; BIOMARKERS, TUMOR; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PROSTATE; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 84942927531     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2015-0206-RA     Document Type: Article

References (47)

1. Robinson BD, Epstein JI. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings. J Urol. 2010; 184(4): 1328-1333.
2. Epstein JI, Netto GJ. Biopsy Interpretation of the Prostate. 5th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015.
3. Zhou M. Intraductal carcinoma of the prostate: The whole story. Pathology. 2013; 45(6): 533-539.
4. Catalona WJ, Kadmon D, Martin SA. Surgical considerations in treatment of intraductal carcinoma of the prostate. J Urol. 1978; 120(2): 259-261.
5. Kovi J, Jackson MA, Heshmat MY. Ductal spread in prostatic carcinoma. Cancer. 1985; 56(7): 1566-1573.
6. Cohen RJ, Wheeler TM, Bonkhoff H, Rubin MA. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma. Arch Pathol Lab Med. 2007; 131(7): 1103-1109.
7. Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod Pathol. 2006; 19(12): 1528-1535.
8. Shah RB, Magi-Galluzzi C, Han B, Zhou M. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies. Am J Surg Pathol. 2010; 34(4): 470-477.
9. Cohen RJ, McNeal JE, Baillie T. Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression. Prostate. 2000; 43(1): 11-19.
10. Watts K, Li J, Magi-Galluzzi C, Zhou M. Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: A prospective cohort study. Histopathology. 2013; 63(4): 574-579.
11. Cohen RJ, Chan WC, Edgar SG, et al. Prediction of pathological stage and clinical outcome in prostate cancer: An improved pre-operative model incorporating biopsy-determined intraductal carcinoma. Br J Urol. 1998; 81(3): 413-418.
12. Van der Kwast T, Al Daoud N, Collette L, et al. Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy. Eur J Cancer. 2012; 48(9): 1318-1325.
13. Dawkins HJ, Sellner LN, Turbett GR, et al. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression. Prostate. 2000; 44(4): 265-270.
14. Wilcox G, Soh S, Chakraborty S, Scardino PT, Wheeler TM. Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Hum Pathol. 1998; 29(10): 1119-1123.
15. Rubin MA, de La Taille A, Bagiella E, Olsson CA, O'Toole KM. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. Am J Surg Pathol. 1998; 22(7): 840-848.
16. McNeal JE, Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol. 1996; 20(7): 802-814.
17. Kimura K, Tsuzuki T, Kato M, et al. Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens. Prostate. 2014; 74(6): 680-687.
18. O'Brien B, Cohen R, Wheeler T, Moorin R. A post-radical-prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis. BJU Int. 2011; 107(3): 389-395.
19. Lotan TL, Gumuskaya B, Rahimi H, et al. Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia. Mod Pathol. 2013; 26(4): 587-603.
20. Bettendorf O, Schmidt H, Staebler A, et al. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate. Genes Chromosomes Cancer. 2008; 47(7): 565-572.
21. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005; 310(5748): 644-648.
22. Clark JP, Cooper CS. ETS gene fusions in prostate cancer. Nat Rev Urol. 2009; 6(8): 429-439.
23. Han B, Suleman K, Wang L, et al. ETS gene aberrations in atypical cribriform lesions of the prostate: implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia. Am J Surg Pathol. 2010; 34(4): 478-485.
24. Tomlins S, Palanisamy N, Siddiqui J, Chinnaiyan A, Kunju L. Antibodybased detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies. Arch Pathol Lab Med. 2012; 136(8): 935-946.
25. Morais CL, Han JS, Gordetsky J, et al. Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy. Am J Surg Pathol. 2015; 39(2): 169-178.
26. Khani F, Epstein JI. Gleason 336 and intraductal carcinoma (IDC-P) on prostate biopsy specimens [abstract 933]. Mod Pathol. 2015; 28(suppl 2): 234A
27. Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: A comparison between ''precursor-like'' and ''regular type'' lesions. Int J Clin Exp Pathol. 2014; 7(5): 2518-2526.
28. Amin MB, Schultz DS, Zarbo RJ. Analysis of cribriform morphology in prostatic neoplasia using antibody to high-molecular-weight cytokeratins. Arch Pathol Lab Med. 1994; 118(3): 260-264.
29. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol. 1993; 24(3): 298-310.
30. Han JS Lee S, Epstein JI, Lotan TL. PINDCIS: Clinical significance of borderline lesions between high grade prostatic intraepithelial neoplasm (HGPIN) and intraductal carcinoma of the prostate (IDC-P) on needle biopsy [abstract 893]. Mod Pathol. 2013; 26(suppl 2): 215A.
31. Samaratunga H, Duffy D, Yaxley J, Delahunt B. Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension. Hum Pathol. 2010; 41(2): 281-285.
32. Seipel AH, Wiklund F, Wiklund NP, Egevad L. Histopathological features of ductal adenocarcinoma of the prostate in 1, 051 radical prostatectomy specimens. Virchows Arch. 2013; 462(4): 429-436.
33. Aydin H, Zhang J, Samaratunga H, et al. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management. BJU Int. 2010; 105(4): 476-480.
34. Herawi M, Epstein JI. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Am J Surg Pathol. 2007; 31(6): 889-894.
35. Bostwick DG, Kindrachuk RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features: clinical, pathologic, and ultrastructural findings. Am J Surg Pathol. 1985; 9(8): 595-609.
36. Epstein JI, Woodruff JM. Adenocarcinoma of the prostate with endometrioid features: A light microscopic and immunohistochemical study of ten cases. Cancer. 1986; 57(1): 111-119.
37. Greene LF, Farrow GM, Ravits JM, Tomera FM. Prostatic adenocarcinoma of ductal origin. J Urol. 1979; 121(3): 303-305.
38. Ro JY, Ayala AG, Wishnow KI, Ordonez NG. Prostatic duct adenocarcinoma with endometrioid features: immunohistochemical and electron microscopic study. Semin Diagn Pathol. 1988; 5(3): 301-311.
39. Christensen WN, Steinberg G, Walsh PC, Epstein JI. Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer. 1991; 67(8): 2118-2124.
40. Fine SW. Variants and unusual patterns of prostate cancer: clinicopathologic and differential diagnostic considerations. Adv Anat Pathol. 2012; 19(4): 204-216.
41. Brinker DA, Potter SR, Epstein JI. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol. 1999; 23(12): 1471-1479.
42. Morgan TM, Welty CJ, Vakar-Lopez F, Lin DW, Wright JL. Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. J Urol. 2010; 184(6): 2303-2307.
43. Amin A, Epstein JI. Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma. Am J Surg Pathol. 2011; 35(4): 615-619.
44. Meeks JJ, Zhao LC, Cashy J, Kundu S. Incidence and outcomes of ductal carcinoma of the prostate in the USA: Analysis of data from the Surveillance, Epidemiology, and End Results program. BJU Int. 2012; 109(6): 831-834.
45. Tavora F, Epstein JI. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: A clinicopathologic study of 28 cases. Am J Surg Pathol. 2008; 32(7): 1060-1067.
46. Hameed O, Humphrey PA. Stratified epithelium in prostatic adenocarcinoma: A mimic of high-grade prostatic intraepithelial neoplasia. Mod Pathol. 2006; 19(7): 899-906.
47. Wu A PN, Siddiqui J, Kunju LP. Utility of GATA-3 and ERG immunohistochemistry in distinguishing between intraductal urothelial carcinoma in the prostate and intraductal carcinoma of the prostate [abstract 1067]. Mod Pathol. 2015; 28(suppl 2): 268A.